サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1138313

細胞分離の世界市場-2022-2029

Global Cell Isolation Market - 2022-2029
出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
細胞分離の世界市場-2022-2029
出版日: 2022年10月18日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場力学

細胞分離の世界市場の成長は、高齢者人口の増加に伴う慢性疾患の有病率の上昇、細胞分離の技術的進歩、バイオ医薬品の需要増加、幹細胞研究の増加といった特定の要因に牽引されています。これらは市場成長を牽引する主要要因の一つです。

慢性疾患の増加により、予測期間中に細胞分離の世界市場を牽引すると予想されます。

世界保健機関（WHO）によると、毎年、世界の死亡者数の13％ががんによって占められています。さらに、今後数十年の間にがん罹患率が70%増加することが予想されており、世界の老年人口はがんにかかりやすいことから、2015年から2022年にかけて、12%から22%にほぼ倍増すると予測されています。地域別では、アジアでのがん罹患率が他の地域と比較して最も高くなっています。文脈上、アジアにおけるがんの罹患人口は2012年に667万人でしたが、2030年には1,084万人に達すると予想されています。アジアにおけるがん罹患率は、他のすべての地域の累積罹患人口と比較して高くなっています。成長率に関しても、この地域のがん罹患率は2.7%という顕著なCAGRで成長しています。欧州のがん罹患率は2番目に高く、次いで北米が高いです。がん罹患率の増加という点では、欧州は予測期間中に最も成長が鈍化すると予想されます。がん罹患率の成長という点では、中東・北アフリカと南米が上位2地域と見なされ、2012年から2030年までのCAGRはそれぞれ3.1%と2.9%です。したがって、世界のがん罹患率の上昇が、細胞分離市場の成長を後押ししています。

厳しい規制、細胞分離装置の高コスト、胚性幹細胞研究に関連する倫理的問題が、細胞分離市場の成長を妨げています。

しかしながら、細胞分離市場は、厳しい規制、細胞分離器具の高コスト、胚性幹細胞研究に関連する倫理的問題など、いくつかの要因によって阻害されています。細胞生物学研究では、動物やヒトを使用することが必要です。これらの細胞は、動物やヒトに害を与える可能性のある薬剤のin vivo毒性試験や薬物動態試験にも使用されています。また、幹細胞研究においては、臨床応用のためにヒト胚を使用するため、胚の破壊につながることも少なくありません。このような活動の監視には厳しい規制が必要であり、世界各地の規制当局によって実施されています。規制機関には、幹細胞研究中央倫理委員会（ZES）、ヒト受精・発生学庁（HFEA）、ヒト組織庁（HTA）、医薬品・医療製品規制庁（MHRA）などがあります。したがって、このような倫理的な懸念や研究用細胞の使用に対する制限が存在するため、細胞生物学研究が制限されています。

COVID-19の影響分析

COVID-19の発生により、研究所はコロナウイルスの症状を早期に抑えることができる解決策を見つけるための研究開発を強化しています。これらの進行中の臨床試験や研究は、細胞分離製品の需要を増加させ、それ故に市場の成長を促進すると予想されます。

産業分析

世界の細胞分離市場は、ポーターのファイブフォース分析、サプライチェーン分析、規制分析、価格分析、アンメットニーズなどの様々な産業要因に基づいて、市場の詳細な分析を提供します。

世界の細胞分離市場レポートでは、約40以上の市場データ表、45以上の図、180ページの構成で提供しています。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

  • 細胞タイプ別市場内訳
  • 細胞ソース別市場内訳
  • 製品別市場内訳
  • 技術別市場内訳
  • アプリケーション別市場内訳
  • エンドユーザー別市場内訳
  • 地域別市場内訳

第4章 市場力学

  • 市場影響要因
    • 促進要因
      • 慢性疾患の増加
      • 細胞分離の技術的進歩
    • 抑制要因
      • 細胞分離に関する厳しい規制とコンプライアンス
  • ビジネスチャンス
  • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • プライシング分析
  • 法規制分析
  • アンメットニーズ分析
  • COVID-19影響度分析

第6章 細胞タイプ別

    • 動物細胞
    • ヒト細胞
      • 幹細胞
      • 分化細胞

第7章 細胞源別

  • 骨髄
  • 脂肪組織
  • 臍帯血・胚性幹細胞

第8章 技術別

  • 表面マーカーによる細胞分離
  • 遠心分離による細胞分離
  • ろ過による細胞分離

第9章 製品別

    • 消耗品
      • 試薬・キット
      • 消耗品
      • ビーズ
    • 装置
      • フローサイトメーター
      • 遠心分離機
      • 磁気活性化セルセパレーターシステム
      • ろ過装置

第10章 アプリケーション別

  • がん研究
  • 幹細胞研究
  • 体外診断薬
  • 生体分子単離
  • 組織再生
  • その他

第11章 エンドユーザー別

  • 病院・診断研究所
  • 研究所、研究機関
  • バイオテクノロジー・バイオ製薬会社
  • 細胞バンク
  • その他

第12章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東とアフリカ

第13章 競合情勢

  • 競合シナリオ
  • 市況ポジショニング／シェア分析
  • M&A（合併・買収）分析

第14章 企業プロファイル

  • Becton Dickinson and Company
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Beckman Coulter, Inc
  • GE Healthcare
  • Merck KgaA
  • Miltenyi Biotec
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories Inc
  • Terumo BCT
  • PluriSelect Life Science UG & Co. KG
  • STEMCELL Technologies Inc（LIST NOT EXHAUSTIVE）

第15章 DataM

目次
Product Code: DMBT2614

Market Overview

Cell Isolation Market is expected to grow at a high CAGR of 17.2% during the forecasting period (2022 - 2029).

Cell isolation (or cell separation) is a process used for sorting cells from a heterogeneous group of cells into the specific populations without contamination. This technique helps many cell-based therapies to improve the quality of the treatment. Cell isolation techniques are widely used for biomolecule isolation for the production of vaccines, drugs, antibodies, enzymes, proteins, and other biotechnology products.

Market Dynamics

The global Cell Isolation market growth driven by certain factors such as rising prevalence of chronic diseases with growing geriatric population, technological advancement in cell isolation, increasing demand for biopharmaceuticals, and increasing stem cell research. are among the key factors driving the market growth.

Rising prevalence of chronic diseases, is expected to drive the global cell isolation market during the forecast period

According to the World Health Organization (WHO), cancer accounts for 13% of deaths globally every year. Moreover, a 70% increase in cancer incidences is anticipated over the next couple of decades and the global geriatric population, as they are more prone to cancer, is anticipated to nearly double from 12% to 22%, from 2015 to 2022. By region, cancer incidence is highest in Asia compared to other regions. Contextually, the incidence population of cancers in Asia was 6.67 million in 2012 and is anticipated to reach 10.84 by 2030. The cancer incidence in Asia is higher compared to the cumulative incidence population of all other regions. In terms of growth rate too, the incidence rate of cancers is growing at a notable CAGR of 2.7% in this region. Europe has the second-highest cancer incidence, followed by North America. In terms of the increase in cancer incidence, Europe is anticipated to have the slowest growth in the forecast period. In terms of growth of cancer incidence, Middle and North Africa and South America are considered to the top two regions with CAGR of 3.1% and 2.9%, from 2012 to 2030, respectively. Hence, with the rising prevalence of cancer globally is driving the growth of the cell isolation market.

Stringent regulations, high cost of cell isolation instruments, and ethical issues related to embryonic stem cell research hampering the growth of the cell isolation market

However, the cell isolation market is hampered by several factors such as stringent regulations, high cost of cell isolation instruments, and ethical issues related to embryonic stem cell research. Cell biology research necessitates the use of animals and humans. These cells are also used for in vivo toxicity and pharmacokinetic testing of drugs, which may harm animals and humans. Also, stem cell research studies use human embryos for clinical applications that often lead to the destruction of embryos. Monitoring of such activities requires stringent regulations which are implemented by regulatory bodies globally. Some of the regulating authorities include Central Ethics Committee for Stem Cell Research (ZES), Human Fertilization and Embryology Authority (HFEA), Human Tissue Authority (HTA), Medicines and Healthcare Products Regulatory Agency (MHRA) and, among others. Hence, with the presence of such ethical concerns and restrictions on the use of cells for research is limiting cell biology research.

COVID-19 Impact Analysis

Due to the outbreak of COVID-19, research labs have increased their research and development to find solutions which can minimize the symptoms of coronavirus at early stages. These ongoing clinical trials and research is expected to increase the demand for cell isolation products, and hence driving the market growth.

Industry Analysis

The global cell isolation market provides in-depth analysis of the market based on various industry factors such as porter's five force analysis, supply chain analysis, regulatory analysis, pricing analysis, unmet needs.

Segment Analysis

The consumables segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The consumables segment accounted for the largest market share in 2019, due to rising investments by major companies to develop technologically advanced products as well as the repetitive use of consumables. Consumables are further classified into reagents & kits, disposables, and beads. On the other hand, the instruments segment is anticipated to grow at the fastest growth rate over the forecast period, owing to advancements in products such as flow cytometers, centrifuges, magnetic-activated cell separator systems, and filtration systems. The innovations in instruments provide efficient cell separation in diagnostics, research, and other applications.

Geographical Analysis

North America region holds the largest market share of the global cell isolation market

North America region is dominating the global cell isolation market accounted for the largest market share in 2021, owing to advanced healthcare infrastructure for life science research, the large presence of major players focusing on the development of novel treatments, and rising prevalence of cancer in this region. For instance, according to the estimates of the GLOBOCAN in 2020, there were an estimated 2,281,658 new cancer cases diagnosed and 612,390 deaths due to cancer in the United States. The Canadian Cancer Society (CCS) estimated that in 2020, approximately 29,800 Canadians would be diagnosed with lung cancer. Represents 13% of all new cancer cases. About 21,200 Canadians are expected to die from lung cancer. Means 25% of all cancer deaths in 2020. In addition, increasing government support for cancer and stem cell research and the expansion of biotechnology and biopharmaceutical industries globally are contributing to the growth of the market. In April 2018, STEMCELL Technologies announced a US$ 45 million joint agreement between the governments of Canada and British Columbia to help the company build an advanced manufacturing facility.

Competitive Landscape

The global cell isolation market is fragmented with major players dominating the market. Some of the major players contributing to the growth of the cell isolation market are Becton Dickinson and Company, Beckman Coulter, Inc., GE Healthcare, Merck KgaA, Miltenyi Biotec, Thermo Fisher Scientific, Bio-Rad Laboratories Inc., among others. The key players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the Cell Isolation market globally. For instance,

In November 2019, MicroMedicine, Inc., a life sciences technology company, launched its patented one-of-a-kind white blood cell isolation technology, the Sorterra Cell Isolation System. This new automated technology gently and reliably isolates white blood cells from human peripheral blood using microfluidic channels without the use of centrifugation or labelling. Sorterra is intended for use in research and development and clinical research labs. Global Cell Isolation Market - Key Companies to Watch

Bio-Rad Laboratories

Overview: Bio-Rad Laboratories, Inc. is an American company that continued to produce innovative and useful products in the healthcare industry that assist life science researchers in accelerating the discovery process, and medical diagnostic labs obtain faster better results.

Product Portfolio: Bio-Plex Multiplex System- The Bio-Plex System offers high-performance readers, industry-leading software, and sensitive assays in ready-to-use or custom configurations, enabling you to obtain high-quality data from limited samples.

The global cell isolation market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Cell Type
  • 3.2. Market snippet by Cell Source
  • 3.3. Market snippet by Product
  • 3.4. Market snippet by Technique
  • 3.5. Market snippet by Application
  • 3.6. Market Snippet by End-User
  • 3.7. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Prevalence of Chronic Diseases
      • 4.1.1.2. Technological Advancement in Cell Isolation
      • 4.1.1.3. XX
    • 4.1.2. Restraints:
      • 4.1.2.1. Strict Regulations and Compliances for Cell Separation
      • 4.1.2.2. XX
  • 4.2. Opportunity
  • 4.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs
  • 5.6. COVID-19 Impact Analysis

6. By Cell Type

  • 6.1. Introduction
  • 6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type Segment
  • 6.3. Market Attractiveness Index, By Cell Type Segment
    • 6.3.1. Animal Cells*
      • 6.3.1.1. Introduction
      • 6.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 6.3.2. Human Cells
      • 6.3.2.1. Stem Cells
      • 6.3.2.2. Differentiated Cells

7. By Cell Source

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source Shape
  • 7.3. Market Attractiveness Index, By Cell Source Segment
    • 7.3.1. Bone Marrow*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Adipose Tissue
    • 7.3.3. Cord Blood/Embryonic Stem Cells

8. By Technique

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique Segment
  • 8.3. Market Attractiveness Index, By Technique Segment
    • 8.3.1. Surface Marker-Based Cell Isolation*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Centrifugation-Based Cell Isolation
    • 8.3.3. Filtration-Based Cell Isolation

9. By Product

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
  • 9.3. Market Attractiveness Index, By Product Segment
    • 9.3.1. Consumables*
      • 9.3.1.1.
      • 9.3.1.1.1. Introduction
      • 9.3.1.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
      • 9.3.1.2. Reagents & kits
      • 9.3.1.3. Disposables
      • 9.3.1.4. Beads
    • 9.3.2. Instruments
      • 9.3.2.1. Flow cytometers
      • 9.3.2.2. Centrifuges
      • 9.3.2.3. Magnetic-activated cell separator systems
      • 9.3.2.4. Filtration systems

10. By Application

  • 10.1. Introduction
  • 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 10.3. Market Attractiveness Index, By Application Segment
    • 10.3.1. Cancer Research*
      • 10.3.1.1. Introduction
      • 10.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 10.3.2. Stem Cell Research
    • 10.3.3. In Vitro Diagnostics
    • 10.3.4. Biomolecule Isolation
    • 10.3.5. Tissue Regeneration
    • 10.3.6. Others

11. By End-User

  • 11.1. Introduction
  • 11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
  • 11.3. Market Attractiveness Index, By End-User Segment
    • 11.3.1. Hospitals and Diagnostic Laboratories*
      • 11.3.1.1. Introduction
      • 11.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 11.3.2. Research Laboratories and Institutes
    • 11.3.3. Biotechnology and Biopharmaceutical Companies
    • 11.3.4. Cell Banks
    • 11.3.5. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type
    • 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source
    • 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 12.2.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.2.9.1. The U.S.
      • 12.2.9.2. Canada
      • 12.2.9.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type
    • 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source
    • 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 12.3.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.3.9.1. Germany
      • 12.3.9.2. The U.K.
      • 12.3.9.3. France
      • 12.3.9.4. Italy
      • 12.3.9.5. Spain
      • 12.3.9.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 12.4.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.9.1. Brazil
      • 12.4.9.2. Argentina
      • 12.4.9.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 12.5.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.5.9.1. China
      • 12.5.9.2. India
      • 12.5.9.3. Japan
      • 12.5.9.4. Australia
      • 12.5.9.5. Rest of Asia Pacific
  • 12.6. The Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Becton Dickinson and Company*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Beckman Coulter, Inc
  • 14.3. GE Healthcare
  • 14.4. Merck KgaA
  • 14.5. Miltenyi Biotec
  • 14.6. Thermo Fisher Scientific
  • 14.7. Bio-Rad Laboratories Inc
  • 14.8. Terumo BCT
  • 14.9. PluriSelect Life Science UG & Co. KG
  • 14.10. STEMCELL Technologies Inc (LIST NOT EXHAUSTIVE)

15. DataM Intelligence

  • 15.1. Appendix
  • 15.2. About Us and Services
  • 15.3. Contact Us